You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mepolizumab

Showing 1 - 25 of 136
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial (Mepolizumab, Spirometry)

Not yet recruiting
  • Asthma
  • Mepolizumab
  • Spirometry
  • (no location specified)
Sep 15, 2023

Chronic Rhinosinusitis With Nasal Polyps Trial (Mepolizumab 100 MG Injection)

Not yet recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Mepolizumab 100 MG Injection
  • (no location specified)
Jun 16, 2023

COPD Trial (Mepolizumab 100 MG)

Not yet recruiting
  • COPD
  • Mepolizumab 100 MG
  • (no location specified)
Oct 20, 2022

Rhinosinusitis Chronic, Polyp, Nasal Trial in Spain (Mepolizumab, Polypeptomy)

Not yet recruiting
  • Rhinosinusitis Chronic
  • Polyp, Nasal
  • Mepolizumab
  • Polypeptomy
  • Bilbao, Spain
  • +6 more
Jun 19, 2023

Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • +2 more
  • Mepolizumab 100 MG
  • Athens, Attiki, Greece
  • +1 more
Sep 29, 2023

Chronic Rhinosinusitis With Nasal Polyps, Asthma, Chronic Rhinosinusitis Without Nasal Polyps Trial (Mepolizumab, Placebo)

Not yet recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • +2 more
  • Mepolizumab
  • Placebo
  • (no location specified)
Nov 29, 2022

Chronic Rhinosinusitis With Nasal Polyps, Asthma Trial (Mepolizumab Injection, Functional Endoscopic Sinus Surgery (FESS).)

Not yet recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Asthma
  • Mepolizumab Injection
  • Functional Endoscopic Sinus Surgery (FESS).
  • (no location specified)
Oct 28, 2022

Chronic Spontaneous Urticaria Trial in Jacksonville (Nucala)

Recruiting
  • Chronic Spontaneous Urticaria
  • Jacksonville, Florida
    Mayo Clinic in Florida
Nov 30, 2022

Gene Transcription and Immunophenotypes Following Mepolizumab

Active, not recruiting
  • Eosinophilic Asthma
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 17, 2023

    Asthma Trial in France (Pre-filled syringe, mepolizumab 100 mg/month, Auto-injector pen, mepolizumab 100 mg/month)

    Not yet recruiting
    • Asthma
    • Pre-filled syringe, mepolizumab 100 mg/month
    • Auto-injector pen, mepolizumab 100 mg/month
    • Besançon, France
    • +7 more
    Nov 15, 2022

    Chronic Rhinosinusitis With Nasal Polyps, Asthma; Eosinophilic, Eosinophilia Trial in Denmark (dupilumab, mepolizumab)

    Recruiting
    • Chronic Rhinosinusitis With Nasal Polyps
    • +2 more
    • dupilumab
    • mepolizumab
    • Aalborg, Denmark
    • +8 more
    Jul 3, 2023

    Asthma, Aspirin-Induced, Chronic Rhinosinusitis With Nasal Polyps Trial in Helsinki (Mepolizumab, Placebo)

    Recruiting
    • Asthma, Aspirin-Induced
    • Chronic Rhinosinusitis With Nasal Polyps
    • Mepolizumab
    • Placebo
    • Helsinki, Finland
      Helsinki University Hospital
    Aug 5, 2022

    Children & Severe Asthma WithEosinophilic Phenotype Treated With

    Recruiting
    • Asthma in Children
    • Mepolizumab
    • London, United Kingdom
      King's College Hospital
    Aug 17, 2022

    Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma:

    Recruiting
    • Asthma
    • Mepolizumab
    • Standard inhaled corticosteroids (ICS) and long-acting beta 2 agonists (LABA)
    • Lund, Skane, Sweden
      The Lung and Allergy Clinic, Skåne University Hospital (SUS)
    Jan 16, 2023

    EoE, Eosinophilic Esophagitis Trial in United States (Mepolizumab 300 mg, Mepolizumab 100 mg, Placebo)

    Completed
    • EoE
    • Eosinophilic Esophagitis
    • Mepolizumab 300 mg
    • +2 more
    • Chicago, Illinois
    • +3 more
    Dec 20, 2022

    Eosinophilic Granulomatosis With Polyangiitis Trial in Tulsa, Norfolk (Depemokimab, Mepolizumab, Placebo matching mepolizumab)

    Not yet recruiting
    • Eosinophilic Granulomatosis With Polyangiitis
    • Depemokimab
    • +3 more
    • Tulsa, Oklahoma
    • +1 more
    Jul 19, 2022

    Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis) Trial (Mepolizumab)

    Not yet recruiting
    • Chronic Rhinosinusitis With Nasal Polyps
    • Chronic Rhinosinusitis (Diagnosis)
    • Mepolizumab
    • (no location specified)
    May 30, 2023

    Asthma; Eosinophilic Trial (Mepolizumab 100 MG)

    Recruiting
    • Asthma
    • Eosinophilic Asthma
    • Mepolizumab 100 MG
    • Ferrol, A Coruña, Spain
    • +4 more
    Sep 5, 2022

    Asthma Trial in Montpellier, Tours (blood sample)

    Not yet recruiting
    • Asthma
    • blood sample
    • Montpellier, France
    • +1 more
    Aug 10, 2022

    Severe Asthma Trial in Jilin (Mepolizumab Injection (BAT2606 Injection), Mepolizumab Injection (EU-licensed Nucala), Mepolizumab

    Recruiting
    • Severe Asthma
    • Mepolizumab Injection (BAT2606 Injection)
    • +2 more
    • Jilin, China
      The First Hospital of Jilin University
    Oct 8, 2022

    Mepolizumab and Physical Activity in Severe Asthma

    Not yet recruiting
    • Asthma
    • Asthma; Eosinophilic
      • (no location specified)
      May 31, 2022

      COPD Trial in Sheffield (Mepolizumab 100 MG)

      Recruiting
      • COPD
      • Mepolizumab 100 MG
      • Sheffield, S Yorkshire, United Kingdom
        Clinical Research Facility - NGH
      May 26, 2022

      Eosinophilic Fasciitis Trial (Mepolizumab)

      Not yet recruiting
      • Eosinophilic Fasciitis
      • Mepolizumab
      • (no location specified)
      Jan 19, 2022

      Mepolizumab Treatment in Nasal Polyps With or Without Bronchial

      Not yet recruiting
      • Chronic Rhinosinusitis With Nasal Polyps
      • Asthma
      • Mepolizumab 100 MG [Nucala]
      • Thessaloniki, Exochi, Greece
        Pulmonary Clinic of Aristotle University of Thessaloniki, George
      Jan 23, 2023

      COPD, Eosinophilia Trial in Leicester (Mepolizumab, Placebo)

      Recruiting
      • COPD
      • Eosinophilia
      • Mepolizumab
      • Placebo
      • Leicester, Leicestershire, United Kingdom
        NIHR Biomedical Research Centre, Respiratory
      Jan 28, 2022